Qualipharma announces the acquisition of Mic & Pharma, a strategic operation that marks a milestone in its growth and consolidation within the pharmaceutical sector. With this integration, the company strengthens its Regulatory Affairs department, positioning itself as a reference company in the national market with a clear international outlook.
Mic & Pharma brings a solid track record and extensive experience in critical areas for the pharmaceutical industry:
• Regulatory Affairs. Management and processing of product registrations, marketing authorizations, reimbursement procedures, price setting and liaison with regulatory authorities.
• Technical consulting. Audits of raw material and packaging suppliers, inspection readiness, staff training, qualification studies and validation activities.
Thanks to this acquisition, Qualipharma expands its capacity to offer comprehensive and tailored solutions, ensuring regulatory compliance and safety throughout all phases of the product life cycle. This move reinforces its commitment to excellence, innovation and quality, which are fundamental pillars of its business strategy.
“The incorporation of Mic & Pharma allows us to take a step forward in our mission to be the strategic partner of choice for the pharmaceutical industry. We are adding talent, knowledge and experience to deliver a more complete and competitive service,” says Gabriel Tallada, CEO of Qualipharma.
Looking to the future
This integration not only strengthens our current structure, but also opens the door to new opportunities. At Qualipharma, we believe in a future where digitalization, sustainability and innovation will be the driving forces transforming the pharmaceutical industry. By combining capabilities and talent, we are prepared to lead this change, delivering solutions that ensure safety and trust in every market where we operate.
